| Year |
Citation |
Score |
| 2023 |
Petővári G, Tóth G, Turiák L, L Kiss A, Pálóczi K, Sebestyén A, Pesti A, Kiss A, Baghy K, Dezső K, Füle T, Tátrai P, Kovalszky I, Reszegi A. Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts. International Journal of Molecular Sciences. 24. PMID 37762298 DOI: 10.3390/ijms241813996 |
0.799 |
|
| 2022 |
Tóth G, Sugár S, Pál D, Fügedi KD, Drahos L, Schlosser G, Oláh C, Reis H, Kovalszky I, Szarvas T, Turiák L. Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival. Cancers. 14. PMID 36230789 DOI: 10.3390/cancers14194867 |
0.499 |
|
| 2022 |
Reszegi A, Tátrai P, Regős E, Kovalszky I, Baghy K. Syndecan-1 in liver pathophysiology. American Journal of Physiology. Cell Physiology. PMID 35704700 DOI: 10.1152/ajpcell.00039.2022 |
0.715 |
|
| 2022 |
Váncza L, Tátrai P, Reszegi A, Baghy K, Kovalszky I. SPOCK1 with unexpected function. The start of a new career. American Journal of Physiology. Cell Physiology. 322: C688-C693. PMID 35235422 DOI: 10.1152/ajpcell.00033.2022 |
0.668 |
|
| 2022 |
Váncza L, Karászi K, Péterfia B, Turiák L, Dezső K, Sebestyén A, Reszegi A, Petővári G, Kiss A, Schaff Z, Baghy K, Kovalszky I. SPOCK1 Promotes the Development of Hepatocellular Carcinoma. Frontiers in Oncology. 12: 819883. PMID 35186754 DOI: 10.3389/fonc.2022.819883 |
0.373 |
|
| 2021 |
Reszegi A, Karászi K, Tóth G, Rada K, Váncza L, Turiák L, Schaff Z, Kiss A, Szilák L, Szabó G, Petővári G, Sebestyén A, Dezső K, Regős E, Tátrai P, ... ... Kovalszky I, et al. Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice. Cancers. 13. PMID 33801718 DOI: 10.3390/cancers13071548 |
0.716 |
|
| 2020 |
Olah C, Tschirdewahn S, Hoffmann MJ, Krafft U, Hadaschik B, Nyirady P, Szendröi A, Módos O, Csizmarik A, Kovalszky I, Reis H, Szarvas T. Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients. Diagnostics (Basel, Switzerland). 10. PMID 33114033 DOI: 10.3390/diagnostics10110864 |
0.527 |
|
| 2020 |
Hollósi P, Váncza L, Karászi K, Dobos K, Péterfia B, Tátrai E, Tátrai P, Szarvas T, Paku S, Szilák L, Kovalszky I. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1. Biomolecules. 10. PMID 32977498 DOI: 10.3390/biom10101356 |
0.791 |
|
| 2020 |
Baghy K, Reszegi A, Tátrai P, Kovalszky I. Decorin in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1272: 17-38. PMID 32845500 DOI: 10.1007/978-3-030-48457-6_2 |
0.738 |
|
| 2020 |
Reszegi A, Horváth Z, Karászi K, Regős E, Postniková V, Tátrai P, Kiss A, Schaff Z, Kovalszky I, Baghy K. The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma. Biomolecules. 10. PMID 32824864 DOI: 10.3390/biom10081199 |
0.739 |
|
| 2020 |
Balogh A, Reiniger L, Hetey S, Kiraly P, Toth E, Karaszi K, Juhasz K, Gelencser Z, Zvara A, Szilagyi A, Puskas LG, Matko J, Papp Z, Kovalszky I, Juhasz C, et al. Decreased Expression of in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival. International Journal of Molecular Sciences. 21. PMID 32796700 DOI: 10.3390/Ijms21165762 |
0.389 |
|
| 2020 |
Nagy N, Reis H, Hadaschik B, Niedworok C, Módos O, Szendrői A, Bíró K, Hager T, Herold T, Ablat J, Black PC, Okon K, Tolkach Y, Csizmarik A, Oláh C, ... ... Kovalszky I, et al. Prevalence of APC and PTEN Alterations in Urachal Cancer. Pathology Oncology Research : Por. PMID 32754865 DOI: 10.1007/S12253-020-00872-6 |
0.602 |
|
| 2020 |
Niedworok C, Kempkensteffen C, Eisenhardt A, Tschirdewahn S, Rehme C, Panic A, Reis H, Baba H, Nyirády P, Hadaschik B, Kovalszky I, Szarvas T. Serum and tissue syndecan-1 levels in renal cell carcinoma. Translational Andrology and Urology. 9: 1167-1176. PMID 32676400 DOI: 10.21037/Tau-19-787 |
0.609 |
|
| 2020 |
Fullár A, Karászi K, Hollósi P, Lendvai G, Oláh L, Reszegi A, Papp Z, Sobel G, Dudás J, Kovalszky I. Two ways of epigenetic silencing of TFPI2 in cervical cancer. Plos One. 15: e0234873. PMID 32559232 DOI: 10.1371/Journal.Pone.0234873 |
0.771 |
|
| 2020 |
Reszegi A, Horváth Z, Fehér H, Wichmann B, Tátrai P, Kovalszky I, Baghy K. Protective Role of Decorin in Primary Hepatocellular Carcinoma. Frontiers in Oncology. 10: 645. PMID 32477937 DOI: 10.3389/Fonc.2020.00645 |
0.752 |
|
| 2020 |
Karászi K, Vigh R, Máthé M, Fullár A, Oláh L, Füle T, Papp Z, Kovalszky I. Aberrant Expression of Syndecan-1 in Cervical Cancers. Pathology Oncology Research : Por. PMID 32388727 DOI: 10.1007/S12253-020-00816-0 |
0.791 |
|
| 2020 |
Tóth G, Vékey K, Sugár S, Kovalszky I, Drahos L, Turiák L. Salt gradient chromatographic separation of chondroitin sulfate disaccharides. Journal of Chromatography. A. 460979. PMID 32093904 DOI: 10.1016/J.Chroma.2020.460979 |
0.313 |
|
| 2019 |
Horváth Z, Reszegi A, Szilák L, Dankó T, Kovalszky I, Baghy K. Tumor-specific inhibitory action of decorin on different hepatoma cell lines. Cellular Signalling. 62: 109354. PMID 31271881 DOI: 10.1016/J.Cellsig.2019.109354 |
0.403 |
|
| 2019 |
Regős E, Karászi K, Reszegi A, Kiss A, Schaff Z, Baghy K, Kovalszky I. Syndecan-1 in Liver Diseases. Pathology Oncology Research : Por. PMID 30826971 DOI: 10.1007/S12253-019-00617-0 |
0.358 |
|
| 2019 |
Karaszi K, Szabo S, Juhasz K, Kiraly P, Kocsis-Deak B, Hargitai B, Krenacs T, Hupuczi P, Erez O, Papp Z, Kovalszky I, Than NG. Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion? Placenta. 76: 30-39. PMID 30803712 DOI: 10.1016/J.Placenta.2019.01.011 |
0.319 |
|
| 2019 |
Mervai Z, Reszegi A, Miklya I, Knoll J, Schaff Z, Kovalszky I, Baghy K. Inhibitory Effect of (2R)-1-(1-Benzofuran-2-yl)-N-propylpentan-2-amine on Lung Adenocarcinoma. Pathology Oncology Research : Por. PMID 30734151 DOI: 10.1007/S12253-019-00603-6 |
0.318 |
|
| 2018 |
Lendvai G, Szekerczés T, Illyés I, Dóra R, Kontsek E, Gógl A, Kiss A, Werling K, Kovalszky I, Schaff Z, Borka K. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis. Pathology Oncology Research : Por. PMID 30448973 DOI: 10.1007/S12253-018-0491-8 |
0.361 |
|
| 2018 |
Kiss K, Regős E, Rada K, Firneisz G, Baghy K, Kovalszky I. Chronic Hyperglycaemia Induced Alterations of Hepatic Stellate Cells Differ from the Effect of TGFB1, and Point toward Metabolic Stress. Pathology Oncology Research : Por. PMID 30109568 DOI: 10.1007/S12253-018-0458-9 |
0.347 |
|
| 2018 |
Krafft U, Reis H, Ingenwerth M, Kovalszky I, Becker M, Niedworok C, Darr C, Nyirády P, Hadaschik B, Szarvas T. Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer. Pathology Oncology Research : Por. PMID 30019121 DOI: 10.1007/S12253-018-0447-Z |
0.607 |
|
| 2018 |
Reis H, van der Vos KE, Niedworok C, Herold T, Módos O, Szendrői A, Hager T, Ingenwerth M, Vis DJ, Behrendt MA, de Jong J, van der Heijden MS, Peyronnet B, Mathieu R, Wiesweg M, ... ... Kovalszky I, et al. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas. International Journal of Cancer. PMID 29672836 DOI: 10.1002/Ijc.31547 |
0.561 |
|
| 2018 |
Szarvas T, Sevcenco S, Módos O, Keresztes D, Nyirády P, Kubik A, Romics M, Kovalszky I, Reis H, Hadaschik B, Shariat SF, Kramer G. Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer. Urologic Oncology. PMID 29628317 DOI: 10.1016/J.Urolonc.2018.03.010 |
0.523 |
|
| 2018 |
Götte M, Kovalszky I. Extracellular matrix functions in lung cancer. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 29499357 DOI: 10.1016/J.Matbio.2018.02.018 |
0.389 |
|
| 2018 |
Regős E, Abdelfattah HH, Reszegi A, Szilák L, Werling K, Szabó G, Kiss A, Schaff Z, Kovalszky I, Baghy K. Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 29454902 DOI: 10.1016/J.Matbio.2018.02.008 |
0.387 |
|
| 2017 |
Felkai L, Bánusz R, Kovalszky I, Sápi Z, Garami M, Papp G, Karászi K, Varga E, Csóka M. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors. Pathology Oncology Research : Por. PMID 29081033 DOI: 10.1007/S12253-017-0332-1 |
0.342 |
|
| 2017 |
Péterfia B, Kalmár A, Patai ÁV, Csabai I, Bodor A, Micsik T, Wichmann B, Egedi K, Hollósi P, Kovalszky I, Tulassay Z, Molnár B. Construction of a multiplex mutation hot spot PCR panel: the first step towards colorectal cancer genotyping on the GS Junior platform. Journal of Cancer. 8: 162-173. PMID 28243320 DOI: 10.7150/Jca.16037 |
0.74 |
|
| 2017 |
Modos O, Keresztes D, Nyirády P, Szendröi A, Tímár J, Szász A, Reis H, Niedworok C, Hadaschik B, Hollósi P, Baghy K, Kovalszky I, Okon K, Golabek T, Chlosta P, et al. Molecular and therapeutic aspects of advanced urachal cancer European Urology Supplements. 16: e2840. DOI: 10.1016/S1569-9056(17)31982-6 |
0.508 |
|
| 2016 |
Butz H, Németh K, Czenke D, Likó I, Czirják S, Zivkovic V, Baghy K, Korbonits M, Kovalszky I, Igaz P, Rácz K, Patócs A. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas. Pathology Oncology Research : Por. PMID 28004354 DOI: 10.1007/S12253-016-0163-5 |
0.323 |
|
| 2016 |
Fullár A, Firneisz G, Regős E, Dudás J, Szarvas T, Baghy K, Ramadori G, Kovalszky I. Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor. Pathology Oncology Research : Por. PMID 27495255 DOI: 10.1007/S12253-016-0095-0 |
0.557 |
|
| 2016 |
Módos O, Reis H, Niedworok C, Rübben H, Szendröi A, Szász MA, Tímár J, Baghy K, Kovalszky I, Golabek T, Chlosta P, Okon K, Peyronnet B, Mathieu R, Shariat SF, et al. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma - occurence and prognostic significance. Oncotarget. PMID 27283768 DOI: 10.18632/Oncotarget.9828 |
0.784 |
|
| 2016 |
Grolmusz VK, Tóth EA, Baghy K, Likó I, Darvasi O, Kovalszky I, Matkó J, Rácz K, Patócs A. Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression. Bmc Genomics. 17: 412. PMID 27234232 DOI: 10.1186/S12864-016-2747-6 |
0.305 |
|
| 2016 |
Szarvas T, Reis H, Vom Dorp F, Tschirdewahn S, Niedworok C, Nyirady P, Schmid KW, Rübben H, Kovalszky I. Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer. The Prostate. 76: 977-85. PMID 27062540 DOI: 10.1002/Pros.23186 |
0.563 |
|
| 2016 |
Jeney A, Hujber Z, Szoboszlai N, Fullár A, Oláh J, Pap É, Márk Á, Kriston C, Kralovánszky J, Kovalszky I, Vékey K, Sebestyén A. Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells. Cancer Cell International. 16: 4. PMID 26869854 DOI: 10.1186/S12935-016-0281-X |
0.334 |
|
| 2016 |
Baghy K, Tátrai P, Regős E, Kovalszky I. Proteoglycans in liver cancer. World Journal of Gastroenterology. 22: 379-93. PMID 26755884 DOI: 10.3748/Wjg.V22.I1.379 |
0.725 |
|
| 2015 |
Kalmár A, Péterfia B, Hollósi P, Galamb O, Spisák S, Wichmann B, Bodor A, Tóth K, Patai ÁV, Valcz G, Nagy ZB, Kubák V, Tulassay Z, Kovalszky I, Molnár B. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. Bmc Cancer. 15: 736. PMID 26482433 DOI: 10.1186/S12885-015-1687-X |
0.761 |
|
| 2015 |
Patai ÁV, Valcz G, Hollósi P, Kalmár A, Péterfia B, Patai Á, Wichmann B, Spisák S, Barták BK, Leiszter K, Tóth K, Sipos F, Kovalszky I, Péter Z, Miheller P, et al. Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas. Plos One. 10: e0133836. PMID 26291085 DOI: 10.1371/Journal.Pone.0133836 |
0.755 |
|
| 2015 |
Kiss K, Baghy K, Spisák S, Szanyi S, Tulassay Z, Zalatnai A, Löhr JM, Jesenofsky R, Kovalszky I, Firneisz G. Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells. Plos One. 10: e0128059. PMID 26010611 DOI: 10.1371/Journal.Pone.0128059 |
0.333 |
|
| 2015 |
Fullár A, Dudás J, Oláh L, Hollósi P, Papp Z, Sobel G, Karászi K, Paku S, Baghy K, Kovalszky I. Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. Bmc Cancer. 15: 256. PMID 25885552 DOI: 10.1186/S12885-015-1272-3 |
0.773 |
|
| 2015 |
Molvarec A, Fügedi G, Molnár M, Schönléber J, Kovalszky I, Rigó J. [268-POS]: Placental expression of the endocannabinoid system in preeclampsia. Pregnancy Hypertension. 5: 134. PMID 25787618 DOI: 10.1016/J.Preghy.2014.10.274 |
0.329 |
|
| 2015 |
Szabo S, Mody M, Romero R, Xu Y, Karaszi K, Mihalik N, Xu Z, Bhatti G, Fule T, Hupuczi P, Krenacs T, Rigo J, Tarca AL, Hassan SS, Chaiworapongsa T, ... Kovalszky I, et al. Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome. Pathology Oncology Research : Por. 21: 659-68. PMID 25583406 DOI: 10.1007/S12253-014-9872-9 |
0.743 |
|
| 2015 |
Modos O, Szarvas T, Reis H, Niedworok C, Rübben H, Szendröi A, Szasz A, Hollosi P, Baghy K, Kovalszky I, Okon K, Golabek T, Chlosta P, Shariat S, Peyronnet B, et al. Mutation analysis of EGFR signal transduction pathway in urachal carcinoma European Urology Supplements. 14: e1215. DOI: 10.1016/S1569-9056(15)30251-7 |
0.49 |
|
| 2015 |
Jozilan H, Horvath P, Kosa J, Lakatos P, Nemeth D, Wölfling J, Kovacs D, Bodnar B, Matyus P, Horvath E, Kovalszky I, Szalay F. P0321 : Increased anti-tumor effect of vitamin D after CYP24A1 inhibition on HCC cell lines Journal of Hepatology. 62: S429. DOI: 10.1016/S0168-8278(15)30536-5 |
0.323 |
|
| 2015 |
Dudas J, Fullar A, Bitsche M, Romani A, Kovalszky I, Riechelmann H. 9 Matrix remodeling in head and neck squamous cell carcinomais Oral Oncology. 51: e30. DOI: 10.1016/J.Oraloncology.2015.02.012 |
0.371 |
|
| 2014 |
Dudás J, Bocsi J, Fullár A, Baghy K, Füle T, Kudaibergenova S, Kovalszky I. Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action. Biomed Research International. 2014: 765794. PMID 25309924 DOI: 10.1155/2014/765794 |
0.777 |
|
| 2014 |
Fullár A, Baghy K, Deák F, Péterfia B, Zsák Y, Tátrai P, Schaff Z, Dudás J, Kiss I, Kovalszky I. Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo. Plos One. 9: e93469. PMID 24691449 DOI: 10.1371/Journal.Pone.0093469 |
0.724 |
|
| 2014 |
Szarvas T, Reis H, Kramer G, Shariat SF, Vom Dorp F, Tschirdewahn S, Schmid KW, Kovalszky I, Rübben H. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer. Human Pathology. 45: 674-82. PMID 24656090 DOI: 10.1016/J.Humpath.2013.10.036 |
0.6 |
|
| 2014 |
Horváth Z, Kovalszky I, Fullár A, Kiss K, Schaff Z, Iozzo RV, Baghy K. Decorin deficiency promotes hepatic carcinogenesis. Matrix Biology : Journal of the International Society For Matrix Biology. 35: 194-205. PMID 24361483 DOI: 10.1016/J.Matbio.2013.11.004 |
0.422 |
|
| 2014 |
Szabó DR, Baghy K, Szabó PM, Zsippai A, Marczell I, Nagy Z, Varga V, Éder K, Tóth S, Buzás EI, Falus A, Kovalszky I, Patócs A, Rácz K, Igaz P. Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer. Cellular and Molecular Life Sciences : Cmls. 71: 917-32. PMID 23807211 DOI: 10.1007/S00018-013-1408-Z |
0.372 |
|
| 2014 |
Molnar B, Peterfia B, Kalmar A, Hollosi P, Nagy ZB, Wichmann B, Kovalszky I, Tulassay Z. Abstract 422: DNA hypermethylation or upregulated miRNA21 expression potentially leads to decreased mRNA expression of COL1A2, SFRP2, SOCS3, BCL2, MAL and PTGS2 in left-sided colorectal adenoma and cancer Cancer Research. 74: 422-422. DOI: 10.1158/1538-7445.Am2014-422 |
0.765 |
|
| 2013 |
Szabo S, Xu Y, Romero R, Fule T, Karaszi K, Bhatti G, Varkonyi T, Varkonyi I, Krenacs T, Dong Z, Tarca AL, Chaiworapongsa T, Hassan SS, Papp Z, Kovalszky I, et al. Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Virchows Archiv : An International Journal of Pathology. 463: 445-58. PMID 23807541 DOI: 10.1007/S00428-013-1426-0 |
0.747 |
|
| 2013 |
Beccari S, Kovalszky I, Wade JD, Otvos L, Surmacz E. Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity. Peptides. 44: 127-34. PMID 23567149 DOI: 10.1016/J.Peptides.2013.03.027 |
0.309 |
|
| 2013 |
Baghy K, Horváth Z, Regős E, Kiss K, Schaff Z, Iozzo RV, Kovalszky I. Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis. The Febs Journal. 280: 2150-64. PMID 23448253 DOI: 10.1111/Febs.12215 |
0.39 |
|
| 2013 |
Dudás J, Fullár A, Romani A, Pritz C, Kovalszky I, Hans Schartinger V, Mathias Sprinzl G, Riechelmann H. Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma. Experimental Cell Research. 319: 800-9. PMID 23247073 DOI: 10.1016/J.Yexcr.2012.12.001 |
0.415 |
|
| 2013 |
Patonai A, Erdélyi-Belle B, Korompay A, Somorácz A, Törzsök P, Kovalszky I, Barbai T, Rásó E, Lotz G, Schaff Z, Kiss A. Molecular characteristics of fibrolamellar hepatocellular carcinoma. Pathology Oncology Research : Por. 19: 63-70. PMID 22872444 DOI: 10.1007/S12253-012-9558-0 |
0.748 |
|
| 2013 |
Péterfia B, Hollósi P, Kalmár A, Galamb O, Spisák S, Wichmann B, Tóth K, Leiszter K, Patai V, Kubák V, Kiss K, Horváth Z, Tulassay Z, Kovalszky I, Molnár B. DNA methylation markers of left-sided colorectal cancer based on gene expression screening Zeitschrift FüR Gastroenterologie. 51. DOI: 10.1055/S-0033-1347506 |
0.314 |
|
| 2013 |
Kalmár A, Peterfia B, Hollosi P, Galamb O, Spisak S, Wichmann B, Tóth K, Leiszter K, Patai ÁV, Kubak V, Kiss K, Horvath Z, Valcz G, Tulassay Z, Kovalszky I, et al. Su1998 Gene Expression-Based High-Throughput Screening Reveals COL12, PTGDR, SFRP2 and SOCS3 As Potential Novel Methylation Markers of Left-Sided Colorectal Cancer Gastroenterology. 144: S-527. DOI: 10.1016/S0016-5085(13)61960-5 |
0.743 |
|
| 2012 |
Spisák S, Kalmár A, Galamb O, Wichmann B, Sipos F, Péterfia B, Csabai I, Kovalszky I, Semsey S, Tulassay Z, Molnár B. Genome-wide screening of genes regulated by DNA methylation in colon cancer development. Plos One. 7: e46215. PMID 23049694 DOI: 10.1371/Journal.Pone.0046215 |
0.351 |
|
| 2012 |
Péterfia B, Füle T, Baghy K, Szabadkai K, Fullár A, Dobos K, Zong F, Dobra K, Hollósi P, Jeney A, Paku S, Kovalszky I. Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2. Plos One. 7: e39474. PMID 22745764 DOI: 10.1371/Journal.Pone.0039474 |
0.788 |
|
| 2012 |
Lendvai G, Kiss A, Kovalszky I, Schaff Z. [MicroRNAs in hepatocarcinogenesis]. Orvosi Hetilap. 153: 978-89. PMID 22714032 DOI: 10.1556/Oh.2012.29387 |
0.326 |
|
| 2012 |
Fullár A, Kovalszky I, Bitsche M, Romani A, Schartinger VH, Sprinzl GM, Riechelmann H, Dudás J. Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma. Experimental Cell Research. 318: 1517-27. PMID 22516051 DOI: 10.1016/J.Yexcr.2012.03.023 |
0.395 |
|
| 2012 |
Baghy K, Iozzo RV, Kovalszky I. Decorin-TGFβ axis in hepatic fibrosis and cirrhosis. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 60: 262-8. PMID 22260996 DOI: 10.1369/0022155412438104 |
0.31 |
|
| 2012 |
Kopper L, Sebestyén A, Gallai M, Kovalszky I. Syndecan-1 - A new piece in B-cell puzzle. Pathology Oncology Research : Por. 3: 183-91. PMID 18470728 DOI: 10.1007/Bf02899919 |
0.339 |
|
| 2012 |
Gyongyosi B, Gyugos M, Kovalszky I, Kiss A, Schaff Z, Lendvai G. 280 MICRORNA EXPRESSION SEEMS TO DIMINISH WITH HEPATOCELLULAR CARCINOMA GRADE Journal of Hepatology. 56: S116. DOI: 10.1016/S0168-8278(12)60293-1 |
0.343 |
|
| 2011 |
Than NG, Romero R, Meiri H, Erez O, Xu Y, Tarquini F, Barna L, Szilagyi A, Ackerman R, Sammar M, Fule T, Karaszi K, Kovalszky I, Dong Z, Kim CJ, et al. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. Plos One. 6: e21564. PMID 21799738 DOI: 10.1371/Journal.Pone.0021564 |
0.717 |
|
| 2011 |
Zong F, Fthenou E, Mundt F, Szatmári T, Kovalszky I, Szilák L, Brodin D, Tzanakakis G, Hjerpe A, Dobra K. Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration. Plos One. 6: e14816. PMID 21731601 DOI: 10.1371/Journal.Pone.0014816 |
0.33 |
|
| 2011 |
Patonai A, Erdélyi-Belle B, Korompay A, Somorácz A, Straub BK, Schirmacher P, Kovalszky I, Lotz G, Kiss A, Schaff Z. Claudins and tricellulin in fibrolamellar hepatocellular carcinoma. Virchows Archiv : An International Journal of Pathology. 458: 679-88. PMID 21503766 DOI: 10.1007/S00428-011-1077-Y |
0.754 |
|
| 2011 |
Szarvas T, Jäger T, Becker M, Tschirdewahn S, Niedworok C, Kovalszky I, Rübben H, Ergün S, vom Dorp F. Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer. Pathology Oncology Research : Por. 17: 325-32. PMID 21253919 DOI: 10.1007/S12253-010-9320-4 |
0.556 |
|
| 2011 |
Baghy K, Dezso K, László V, Fullár A, Péterfia B, Paku S, Nagy P, Schaff Z, Iozzo RV, Kovalszky I. Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 439-51. PMID 20956977 DOI: 10.1038/Labinvest.2010.172 |
0.352 |
|
| 2011 |
Horvath E, Lakatos P, Balla B, Kósa P, Kovalszky I, Pesti V, Németh D, Hasan J, Korompay A, Somorácz Á, Schaff Z, Kupcsulik P, Szalay F. Increased CYP24A1 mRNA expression after 1,25-Dihydroxyvitamin D3 treatment of hepatocellular carcinoma cell lines in vitro and also in human liver cancer Zeitschrift FüR Gastroenterologie. 49. DOI: 10.1055/S-0031-1278459 |
0.404 |
|
| 2011 |
Somorácz A, Tátrai P, Lendvai G, Baghy K, Kiss A, Kovalszky I, Schaff Z. 1084 POSTER Claudin-1 Acts as a Tumour Suppressor in Hepatoma Cell Lines European Journal of Cancer. 47: S120. DOI: 10.1016/S0959-8049(11)70727-4 |
0.301 |
|
| 2011 |
Horvath E, Lakatos P, Balla B, Kosa J, Kovalszky I, Szalay F. 224 REMARKABLE INCREASE IN CYP24A1 MRNA LEVEL AFTER 1,25-DIHYDROXYVITAMIN D3 TREATMENT OF HEPATOCELLULAR CARCINOMA CELL LINES Journal of Hepatology. 54: S94. DOI: 10.1016/S0168-8278(11)60226-2 |
0.316 |
|
| 2011 |
Horváth E, Lakatos P, Balla B, Kosa JP, Kovalszky I, Szalay F. Significant Increase in CYP24A1 mRNA Level After 1,25-Dihydroxyvitamin D3 Treatment of Hepatocellular Carcinoma Cell Lines Gastroenterology. 140: S-978. DOI: 10.1016/S0016-5085(11)64051-1 |
0.318 |
|
| 2010 |
Lendvai G, Kiss A, Kovalszky I, Schaff Z. [Alterations in microRNA expression patterns in liver diseases]. Orvosi Hetilap. 151: 1843-53. PMID 20980222 DOI: 10.1556/Oh.2010.28985 |
0.321 |
|
| 2010 |
Schaff Z, Kovalszky I, Lotz G, Kiss A. [Hepatocellular carcinoma--from macroscopy to molecular pathology]. Orvosi Hetilap. 151: 982-9. PMID 20519181 DOI: 10.1556/Oh.2010.28875 |
0.397 |
|
| 2010 |
Somorácz A, Tátrai P, Horváth G, Kiss A, Kupcsulik P, Kovalszky I, Schaff Z. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas. Human Pathology. 41: 1310-9. PMID 20471664 DOI: 10.1016/J.Humpath.2009.10.029 |
0.8 |
|
| 2010 |
Tátrai P, Egedi K, Somorácz A, van Kuppevelt TH, Ten Dam G, Lyon M, Deakin JA, Kiss A, Schaff Z, Kovalszky I. Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 58: 429-41. PMID 20124094 DOI: 10.1369/Jhc.2010.955161 |
0.79 |
|
| 2010 |
Zong F, Fthenou E, Castro J, Péterfia B, Kovalszky I, Szilák L, Tzanakakis G, Dobra K. Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains. Cell Proliferation. 43: 29-40. PMID 19840029 DOI: 10.1111/J.1365-2184.2009.00651.X |
0.342 |
|
| 2009 |
Zong F, Fthenou E, Wolmer N, Hollósi P, Kovalszky I, Szilák L, Mogler C, Nilsonne G, Tzanakakis G, Dobra K. Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells. Plos One. 4: e7346. PMID 19802384 DOI: 10.1371/Journal.Pone.0007346 |
0.738 |
|
| 2009 |
Pap Z, Pávai Z, Dénes L, Kovalszky I, Jung J. An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1. Pathology Oncology Research : Por. 15: 579-87. PMID 19253033 DOI: 10.1007/S12253-009-9157-X |
0.361 |
|
| 2009 |
Tátrai P, Somorácz A, Batmunkh E, Schirmacher P, Kiss A, Schaff Z, Nagy P, Kovalszky I. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions. The American Journal of Surgical Pathology. 33: 874-85. PMID 19194276 DOI: 10.1097/Pas.0B013E318194B3Ea |
0.778 |
|
| 2009 |
Szarvas T, Jäger T, Droste F, Becker M, Kovalszky I, Romics I, Ergün S, Rübben H. Serum levels of angiogenic factors and their prognostic relevance in bladder cancer. Pathology Oncology Research : Por. 15: 193-201. PMID 18807212 DOI: 10.1007/S12253-008-9107-Z |
0.589 |
|
| 2008 |
Szarvas T, Jäger T, Tötsch M, vom Dorp F, Kempkensteffen C, Kovalszky I, Romics I, Ergün S, Rübben H. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 8253-62. PMID 19088043 DOI: 10.1158/1078-0432.Ccr-08-0677 |
0.569 |
|
| 2008 |
Than NG, Abdul Rahman O, Magenheim R, Nagy B, Fule T, Hargitai B, Sammar M, Hupuczi P, Tarca AL, Szabo G, Kovalszky I, Meiri H, Sziller I, Rigo J, Romero R, et al. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Archiv : An International Journal of Pathology. 453: 387-400. PMID 18791734 DOI: 10.1007/S00428-008-0658-X |
0.735 |
|
| 2008 |
László V, Dezso K, Baghy K, Papp V, Kovalszky I, Sáfrány G, Thorgeirsson SS, Nagy P, Paku S. Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes. Histochemistry and Cell Biology. 130: 1005-14. PMID 18663461 DOI: 10.1007/S00418-008-0482-Z |
0.36 |
|
| 2008 |
Szabó E, Korpos E, Batmunkh E, Lotz G, Holczbauer A, Kovalszky I, Deák F, Kiss I, Schaff Z, Kiss A. Expression of matrilin-2 in liver cirrhosis and hepatocellular carcinoma. Pathology Oncology Research : Por. 14: 15-22. PMID 18386166 DOI: 10.1007/S12253-008-9005-4 |
0.434 |
|
| 2008 |
Kulka J, Kovalszky I, Svastics E, Berta M, Füle T. Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive. Human Pathology. 39: 298-301. PMID 18206498 DOI: 10.1016/J.Humpath.2007.08.006 |
0.747 |
|
| 2008 |
Tatrai P, Somoracz A, Batmunkh E, Kiss A, Schirmacher P, Nagy P, Schaff Z, Kovalszky I. 414 IMMUNOHISTOCHEMISTRY FOR AGRIN AND CD34 IN THE DISCRIMINATION OF BENIGN VERSUS MALIGNANT LESIONS OF THE LIVER PARENCHYMA Journal of Hepatology. 48: S160. DOI: 10.1016/S0168-8278(08)60416-X |
0.361 |
|
| 2007 |
Riesz P, Lotz G, Páska C, Szendrôi A, Majoros A, Németh Z, Törzsök P, Szarvas T, Kovalszky I, Schaff Z, Romics I, Kiss A. Detection of bladder cancer from the urine using fluorescence in situ hybridization technique. Pathology Oncology Research : Por. 13: 187-94. PMID 17922047 DOI: 10.1007/Bf02893498 |
0.583 |
|
| 2007 |
Batmunkh E, Tátrai P, Szabó E, Lódi C, Holczbauer A, Páska C, Kupcsulik P, Kiss A, Schaff Z, Kovalszky I. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Human Pathology. 38: 1508-15. PMID 17640714 DOI: 10.1016/J.Humpath.2007.02.017 |
0.742 |
|
| 2007 |
Szarvas T, Kovalszky I, Bedi K, Szendroi A, Majoros A, Riesz P, Füle T, László V, Kiss A, Romics I. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment. Oncology Reports. 18: 405-9. PMID 17611663 |
0.789 |
|
| 2007 |
Ujpál M, Barabás J, Kovalszky I, Szabó G, Németh Z, Gábris K, Suba Z. A preliminary comparative study of the prognostic implications of type 2 diabetes mellitus for patients with primary gingival carcinoma treated with surgery and radiation therapy. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 65: 452-6. PMID 17307592 DOI: 10.1016/J.Joms.2006.09.015 |
0.349 |
|
| 2007 |
Botos E, Turi A, Müllner N, Kovalszky I, Tátrai P, Kiss AL. Regulatory role of kinases and phosphatases on the internalisation of caveolae in HepG2 cells. Micron (Oxford, England : 1993). 38: 313-20. PMID 16713271 DOI: 10.1016/J.Micron.2006.03.012 |
0.677 |
|
| 2007 |
Szarvas T, Kovalszky I, Bedi K, Szendroi A, Majoros A, Riesz P, Füle T, László V, Kiss A, Romics I. Deletion analysis of tumor and urinary DNA to detect bladder cancer: Urine supernatant versus urine sediment Oncology Reports. 18: 405-409. DOI: 10.3892/Or.18.2.405 |
0.79 |
|
| 2006 |
Tátrai P, Dudás J, Batmunkh E, Máthé M, Zalatnai A, Schaff Z, Ramadori G, Kovalszky I. Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 86: 1149-60. PMID 16983329 DOI: 10.1038/Labinvest.3700475 |
0.731 |
|
| 2006 |
Péterfia B, Hollósi P, Szilák L, Timár F, Paku S, Jeney A, Kovalszky I. [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma]. Magyar Onkologia. 50: 115-20. PMID 16888674 |
0.759 |
|
| 2006 |
Füle T, Máthé M, Suba Z, Csapó Z, Szarvas T, Tátrai P, Paku S, Kovalszky I. The presence of human papillomavirus 16 in neural structures and vascular endothelial cells. Virology. 348: 289-96. PMID 16499942 DOI: 10.1016/J.Virol.2005.12.043 |
0.758 |
|
| 2006 |
Lódi C, Szabó E, Holczbauer A, Batmunkh E, Szíjártó A, Kupcsulik P, Kovalszky I, Paku S, Illyés G, Kiss A, Schaff Z. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 460-9. PMID 16439986 DOI: 10.1038/Modpathol.3800549 |
0.463 |
|
| 2006 |
Máthé M, Suba Z, Németh Z, Tátrai P, Füle T, Borgulya G, Barabás J, Kovalszky I. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncology. 42: 493-500. PMID 16364677 DOI: 10.1016/J.Oraloncology.2005.10.003 |
0.8 |
|
| 2006 |
Füle T, Csapó Z, Máthé M, Tátrai P, László V, Papp Z, Kovalszky I. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecologic Oncology. 100: 570-8. PMID 16325245 DOI: 10.1016/J.Ygyno.2005.09.019 |
0.759 |
|
| 2006 |
Firneisz G, Dudás J, Szarvas T, Sári E, Ramadori G, Kovalszky I. Different transforming growth factor-B1 induces extracellular matrix production in rat hepatic stellate cells versus hepatic myofibroblasts, but decorin inhibits both Zeitschrift FüR Gastroenterologie. 44. DOI: 10.1055/s-2006-943392 |
0.507 |
|
| 2005 |
Harisi R, Dudás J, Timár F, Pogány G, Timár J, Kovalszky I, Szendroi M, Jeney A. Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture Cell Biology International. 29: 959-967. PMID 16242975 DOI: 10.1016/J.Cellbi.2005.08.010 |
0.354 |
|
| 2005 |
Sobel G, Szabó I, Páska C, Kiss A, Kovalszky I, Kádár A, Paulin F, Schaff Z. Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia. Pathology Oncology Research : Por. 11: 26-31. PMID 15800679 DOI: 10.1007/Bf03032402 |
0.365 |
|
| 2005 |
Firneisz G, Dudás J, Saile B, Szarvas T, Lengyel G, Tulassay Z, Fehér J, Kovalszky I, Ramadori G. TGFB1 and decorin induced extracellular matrix protein production of hepatic stellate cells and myofibroblasts Zeitschrift FüR Gastroenterologie. 43. DOI: 10.1055/S-2005-869673 |
0.509 |
|
| 2004 |
Kovalszky I, Dudás J, Gallai M, Hollósi P, Tátrai P, Tátrai E, Schaff Z. [Proteoglycans in the liver]. Magyar Onkologia. 48: 207-13. PMID 15520870 |
0.799 |
|
| 2002 |
Tímár J, Lapis K, Dudás J, Sebestyén A, Kopper L, Kovalszky I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Seminars in Cancer Biology. 12: 173-86. PMID 12083848 DOI: 10.1016/S1044-579X(02)00021-4 |
0.387 |
|
| 2002 |
Füle T, Kovalszky I. [The molecular diagnostics of viruses]. Magyar Onkologia. 46: 17-22. PMID 12050678 |
0.728 |
|
| 2001 |
Ladányi A, Gallai M, Paku S, Nagy JO, Dudás J, Tímár J, Kovalszky I. Expression of a decorin-like moleculein human melanoma. Pathology Oncology Research : Por. 7: 260-6. PMID 11882905 DOI: 10.1007/Bf03032382 |
0.37 |
|
| 2001 |
Dudás J, Kovalszky I, Gallai M, Nagy JO, Schaff Z, Knittel T, Mehde M, Neubauer K, Szalay F, Ramadori G. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. American Journal of Clinical Pathology. 115: 725-35. PMID 11345837 DOI: 10.1309/J8Cd-E9C8-X4Ng-Gtvg |
0.344 |
|
| 2001 |
Varkonyi J, Kovalszky I, Nemeth A, Demeter J, Raposa T. Increased risk for cancer in multiple myeloma patients and their first-degree relatives. Haematologia. 31: 45-50. PMID 11345403 DOI: 10.1163/15685590151092698 |
0.313 |
|
| 2000 |
Sebestyén A, Gallai M, Knittel T, Ambrust T, Ramadori G, Kovalszky I. Cytokine regulation of syndecan expression in cells of liver origin. Cytokine. 12: 1557-60. PMID 11023673 DOI: 10.1006/Cyto.2000.0754 |
0.327 |
|
| 2000 |
Jármay K, Gallai M, Karácsony G, Ozsvár Z, Schaff Z, Lonovics J, Kovalszky I. Decorin and actin expression and distribution in patients with chronic hepatitis C following interferon-alfa-2b treatment. Journal of Hepatology. 32: 993-1002. PMID 10898320 DOI: 10.1016/S0168-8278(00)80104-X |
0.332 |
|
| 2000 |
DUDÁS J, RAMADORI G, KNITTEL T, NEUBAUER K, RADDATZ D, EGEDY K, KOVALSZKY I. Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate Biochemical Journal. 350: 245. DOI: 10.1042/0264-6021:3500245 |
0.378 |
|
| 1999 |
Schaff Z, Kovalszky I, Nagy P, Zalatnai A, Jeney A, Lapis K. Human and experimental hepatocarcinogenesis. Scandinavian Journal of Gastroenterology. Supplement. 228: 90-7. PMID 9867118 DOI: 10.1080/003655298750026615 |
0.391 |
|
| 1999 |
Kovalszky I, Nagy P, Szende B, Lapis K, Szalay F, Jeney A, Schaff Z. Experimental and human liver fibrogenesis. Scandinavian Journal of Gastroenterology. Supplement. 228: 51-5. PMID 9867113 DOI: 10.1080/003655298750026561 |
0.34 |
|
| 1998 |
Kovalszky I, Dudás J, Oláh-Nagy J, Pogány G, Töváry J, Timár J, Kopper L, Jeney A, Iozzo RV. Inhibition of DNA topoisomerase I activity by heparan sulfate and modulation by basic fibroblast growth factor. Molecular and Cellular Biochemistry. 183: 11-23. PMID 9655174 DOI: 10.1023/A:1006898920637 |
0.326 |
|
| 1997 |
Tóvári J, Paku S, Rásó E, Pogány G, Kovalszky I, Ladányi A, Lapis K, Tímár J. Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation. International Journal of Cancer. 71: 825-31. PMID 9180152 DOI: 10.1002/(Sici)1097-0215(19970529)71:5<825::Aid-Ijc21>3.0.Co;2-5 |
0.352 |
|
| 1997 |
Gallai M, Sebestyén A, Nagy P, Kovalszky I, Onody T, Thorgeirsson SS. Proteoglycan gene expression in rat liver after partial hepatectomy. Biochemical and Biophysical Research Communications. 228: 690-4. PMID 8941340 DOI: 10.1006/Bbrc.1996.1718 |
0.359 |
|
| 1997 |
Jeney A, Kovalszky I, Timár F, Schaff Z, Zalatnai A, Lapis K, Oláh J, Divald A, Szende B. Modification of pathobiological events by potential hepatopharmacological agents Inflammopharmacology. 5: 93-103. DOI: 10.1007/Bf02679010 |
0.319 |
|
| 1994 |
Kovalszky I, Gallai M, Armbrust T, Ramadori G. Syndecan-1 gene expression in isolated rat liver cells (hepatocytes, Kupffer cells, endothelial and Ito cells). Biochemical and Biophysical Research Communications. 204: 944-949. PMID 7980565 DOI: 10.1006/Bbrc.1994.2551 |
0.356 |
|
| 1993 |
Schaff Z, Kovalszky I, Sarosi I, Jeney A, Friedman R. Pathobiology of preneoplasia and incipient neoplasia of the liver European Journal of Cancer. 29: S39. DOI: 10.1016/0959-8049(93)90810-3 |
0.309 |
|
| 1992 |
Kovalszky I, Szeberenyi S, Zalatnai A, Vincze I, Lapis K, Jeney A. Modification of DENA-induced hepatocarcinogenesis by CCl4 cirrhosis. Comparison of the marker enzyme patterns. Carcinogenesis. 13: 773-8. PMID 1350234 DOI: 10.1093/Carcin/13.5.773 |
0.356 |
|
| 1991 |
Kovalszky I, Kralovánszky J, Jeney A, Lapis K, Karácsonyi S, Széchény A. Alkaline phosphatase activity in human and rat liver tumors. Oncology. 48: 144-8. PMID 1847742 DOI: 10.1159/000226914 |
0.396 |
|
| 1990 |
Kovalszky I, Pogany G, Molnar G, Jeney A, Lapis K, Karacsonyi S, Szecseny A, Iozzo RV. Altered glycosaminoglycan composition in reactive and neoplastic human liver. Biochemical and Biophysical Research Communications. 167: 883-90. PMID 2157432 DOI: 10.1016/0006-291X(90)90606-N |
0.38 |
|
| 1979 |
Szepesházi K, Lapis K, Jeney A, Szende B, Schawartz J, Ujhelyi E, Takács J, Kovalszky I, Tompa A. Morphological and biochemical studies on the effect of agents with liver protecting properties. Experimentelle Pathologie. 15: 271-87. PMID 729706 DOI: 10.1016/S0014-4908(78)80067-2 |
0.309 |
|
| 1979 |
Jeney A, Kovalszky I, Gyapay G, Lapis K, Suba Z. Chromatin alterations and gene function disorder in MC-29 virus-derived hepatoma. Journal of Toxicology and Environmental Health. 5: 509-16. PMID 224207 DOI: 10.1080/15287397909529762 |
0.309 |
|
| Show low-probability matches. |